Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
+0.03 (0.18%)
Apr 19, 2024, 4:00 PM EDT - Market closed

Kiniksa Pharmaceuticals Revenue

In the year 2023, Kiniksa Pharmaceuticals had annual revenue of $270.26M with 22.74% growth. Revenue in the quarter ending December 31, 2023 was $83.40M with 34.76% year-over-year growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.19B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023270.26M50.08M22.74%
Dec 31, 2022220.18M181.64M471.24%
Dec 31, 202138.54M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition